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Summary 
Inositol 1,4,5-trisphosphate (IP3)-mediated calcium 
(Ca 2+) signaling is subject to cytosolic and luminal reg- 
ulatory mechanisms. In Xenopus oocytes, Ca2+-sensi -
tive gating of the IP3 receptor (IP3R) produces repeti- 
tive waves of Ca 2+ release. We examined the role of 
the luminal Ca2+-binding protein calreticulin (CRT) in 
IP3-mediated Ca 2* signaling by using Ca 2* wave activity 
as a sensitive Ca 2÷ release assay. Overexpression of 
CRT inhibited repetitive IP3-induced Ca 2+ waves. Dele- 
tion mutagenesis demonstrated that CRT inhibition 
was mediated by the high affinity-low capacity Ca 2+- 
binding domain, which contributes little to Ca 2+ stor- 
age. This novel function of CRT in intracellular Ca 2÷ 
signaling may be regulated by Ca 2+ occupancy of the 
high affinity binding site. 
Introduction 
Intracellular Ca 2+ release is a point of convergence for 
many hormone receptor signaling pathways (Berridge, 
1993; Pozzan et al., 1994; Putney and Bird, 1993; Tsien 
and Tsien, 1990). Oscillations in intracellular Ca 2+ arise 
from activation of either inositol 1,4,5-trisphosphate r cep- 
tors (IP3Rs) or ryanodine receptors. The Ca 2+ sensitivity of 
both activated receptors is such that at low concentrations, 
Ca 2÷ induces Ca 2+ release (CICR), while at higher concen- 
trations, Ca 2+ is inhibitory (Bezprozvanny et al., 1991; 
Finch et al., 1991; lino, 1990). In Xenopus oocytes, only 
IP3Rs appear to be expressed (Callamaras and Parker, 
1994; Parys et al., 1992), and their activation leads to com- 
plex spatiotemporal patterns of repetitive Ca 2+ release 
(Lechleiter et al., 1991; Lechleiter and Clapham, 1992; 
Parker and Yao, 1991). Although the general properties 
of Ca 2+ release can be described by the dependence of 
the IP3-bound IP3R ion channel on Ca 2+, regulation may 
be more complex. We have previously demonstrated that 
cytoplasmic clearing and refilling of the stores by Ca 2+- 
ATPases increases the frequency of the propagating 
waves of Ca 2+ release (Camacho and Lechleiter, 1993). 
Changes in IP3 concentration can also modulate the de- 
sensitization of the IP3R ion channel (Hajn6czky and 
Thomas, 1994). In addition, luminal Ca 2+ concentration 
may be an important determinant of channel activity (Mis- 
siaen et al., 1992). 
Ca2+-binding proteins located in the lumen of the endo- 
plasmic reticulum (ER) are potential regulators of intracel- 
lular Ca 2÷ release (Brillantes et al., 1994; Ikemoto et al., 
1989; Kawasaki and Kasai, 1994; Michalak et al., 1992). 
In muscle cells, the predominant ER luminal Ca2+-binding 
protein is calsequestrin, where it is thought to reduce the 
Ca 2÷ gradient against which the Ca2+-ATPases must work 
to refill the stores (Lytton and MacLennan, 1991). In non- 
muscle cells, the predominant Ca2+-binding protein in the 
ER lumen is calreticulin (CRT) (Milner et al., 1991). CRT is 
a highly conserved 400 amino acid peripheral membrane 
protein of the ER lumen (Michalak et al., 1992). Like 
calsequestrin, CRT has a large stretch of negatively 
charged residues at the COOH-terminus (C domain) that 
binds Ca 2+ with low affinity (K~ = 0.3-2.0 mM) and high 
capacity (Br, ax = 20-50 mol/mol of protein) (Michalak et 
al., 1992). On the basis of this sequence similarity, the 
presumed role of CRT in intracellular Ca 2+ release has 
been luminal Ca 2+ storage (Michalak et al., 1992). In sup- 
port of this, decreased expression of CRT in NG-108-15 
cells lowered the Ca 2+ response to the agonist bradykinin, 
suggesting a relationship between CRT levels and Ca 2+ 
storage capacity (Liu et al., 1994). CRT also has a high 
affinity (Kd = 1.6 #M), low capacity (Br,~ = 1 mol/mol 
of protein) Ca2+-binding domain (P domain) (rBaksh and 
M ichalak, 1991; Michalak et al., 1992), although the func- 
tion of this domain in Ca 2÷ signaling is unknown. This do- 
main consists of a charged region containing a 17 amino 
acid repeat (PxxlxDPDAxKPEDWDE), followed by a pro- 
line, serine, and threonine-rich segment. The NH2-terminal 
domain of CRT forms a globular domain with a helix-turn- 
helix motif and does not bind Ca 2÷ (Baksh and Michalak, 
1991). This domain may be involved in the CRT-induced 
inhibition of transcription by steroid hormone receptors 
(Burns et al., 1994; Dedhar et al., 1994). 
In this study, we examine the role of the luminal Ca 2+- 
binding protein CRT in the regulation of IP3-mediated Ca 2+ 
release. CRT has been postulated to participate in intracel- 
lular Ca 2+ signaling on the basis of its ability to store Ca 2+ 
within the C domain. Here, we directly test this hypothesis 
by examining the effects of CRT overexpression on IP3- 
induced repetitive Ca 2+ wave activity in Xenopus oocytes. 
Surprisingly, we found that CRT does not affect the peak 
amplitude of IP3-mediated Ca 2÷ release. However, CRT 
overexpression does reduce the occurrence and fre- 
quency of repetitive Ca 2+ wave activity. By deletion muta- 
genesis analysis of CRT, we show that these inhibitory 
effects are mediated by the P domain of CRT. We conclude 
that CRT directly (or indirectly, via accessory proteins) 
interacts with either the IP3R or Ca2+-ATPases. We also 
propose that the high affinity Ca2+-binding site of CRT be- 
haves as a luminal Ca 2+ sensor for store depletion. 
Results 
Overexpression of CRT Inhibits Repetitive 
Ca 2÷ Waves 
To test the role of CRT in IP3-mediated Ca 2~ signaling, 
oocytes from albino Xenopus laevis were injected with 
mRNA encoding rabbit CRT (Fliegel et al., 1989) and as- 
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Figure 2. Protein Analysis of CRT, CRT Deletion Mutants, and 
SERCA2b 
(A) In vitro translation/~iotinylations f CRT and CRT deletion mutants. 
CRT, AC, and Ap migrate as single bands of -60  kDa (lane 1), -40  
kDa (lane 2), and -40  kDa (lane 3), respectively. A reaction without 
input RNA served as negative control (lane 4). Lanes 1,2, and 4 were 
loaded with 2 p.I of translation product (from a 50 ~1 volume reaction), 
and lane 3 was loaded with 3 p.I of translation product. The translation 
products were run on a 12% SDS gel. Molecular size markers are 
indicated on the right (Bio-Rad, Broad Range, Melville, New York). 
(B) Protein immunoblot analysis of SERCA2b of extracts from oocytes 
expressing SERCA2b and H20 (lane 1), SERCA2b and CRT (lane 2), 
SERCA2b and AC (lane 3), SERCA2b and AP (lane 4), and SERCA2b 
and APC (lane 5). The SERCA2b product was probed by a rabbit 
primary antibody to rat SERCAs (C-4, gift of D. MacLennan and J. 
Lytton). A replica blot of the same oocyte extracts was probe~l with 
pre-immune serum, yielding no immunoreactivity (gift of J. Lytton; data 
not shown). Molecular size markers are indicated on the right (Bio-Rad, 
High Range, Melville, New York). Extracts were run on a 10% SDS gel. 
(C) Protein immunoblot analysis of CRT and CRT deletion mutants 
carried out with the same extracts as in (B): SERCA2b and H~O (lane 
1), SERCA2b and CRT (lane 2), SERCA2b and AC (lane 3), SERCA2b 
and AP (lane 4). CRT and CRT deletion mutants were probed by a 
goat anti-rabbit CRT primary antibody (gift of M. Michalak). Identical 
results were obtained on a replica blot of these oocyte extracts when 
probed with a KDEL primary antibody (gift of M. Michalak; data not 
shown). Molecular sizes as in (A). One oocyte equivalent was loaded 
in each lane and run on a 12% SDS gel. 
Figure 1. CRT Expression Inhibits IP3-1nduced Repetitive Ca 2÷ Wave 
Activity 
(A and B) Comparison of the IP3 ( -300 nM)-induced Ca z- response 
in a control oocyte (injected with H20 instead of mRNA) with the re- 
sponse of a CRT-expressing oocyte. 
(C) Expression of SERCA2b results in high frequency IP3-induced Ca 2÷ 
wave activity, with no preceding tide of Ca 2+ release. 
(D) Coexpression of CRT with SERCA2b strongly inhibits IPa-induced 
Ca 2+ wave activity. Slow frequency repetitive waves are also observed 
from 180 s to 300 s. This oocyte would be classified as.a mixed wave 
response (Ca 2÷ tide and repetitive waves; see Table 1 ). Individual con- 
focal images (725 ~rn x 725 ~m) of Ca 2÷ wave activity were taken at 
the indicated times. The bottom trace in each panel represents the 
change in fluorescence (AF/F) for a 5 x 5 pixel area (indicated as a 
white square in the first panel of each experiment) shown as a function 
of time. Note that the initial rate of rise of the AF/F trace is due primarily 
to the injection of IP3. 
sayed for IP3-induced Ca  2+ wave activity 4 -6  days after  
mRNA injection. Confoca l  images  of intracel lu lar  Ca  2÷ 
were  recorded f rom a s ingle opt ical  sl ice near  the p lasma 
membrane sur face  at 1 s intervals.  In control  oocytes  in- 
jected with H20 instead of  mRNA,  IP3 ( -  300 nM final con- 
centrat ion)  init iated a large wave  of  Ca  2÷ re lease envel -  
oping the oocyte  (F igure 1A). This Ca 2÷ t ide (Tsien and 
Tsien, 1990) was  fo l lowed by repet i t ive Ca ~÷ waves  in 57% 
of  control  oocytes  (Table 1; cf. Camacho and Lechleiter ,  
1993; Lechle i ter  and C lapham,  1992). When CRT was ex-  
pressed,  the number  of  oocytes  exhibit ing repetit ive Ca  2÷ 
waves  was  reduced (Table 1). The major i ty of  CRT-  
express ing  oocytes  showed only the initial t ide of Ca  2÷ 
(Figure 1 B). Addit ional ly,  in those mRNA- in jected  oocytes  
that d isp layed repetit ive Ca  2÷ wave activity (45S/o), the pe- 
riod between success ive  waves  was  near ly  double  that of 
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Table 1. Inhibition of Repetitive Ca 2÷ Wave Activity by Calreticulin and High Affinity CaZ+-Binding Mutant 
Ca 2÷ Wave Activity 
Tide Tide b and 
Peak Amplitude ~ Wave Repetitive Repetitive 
Only Waves Waves Only Wave Period 
Type AF/F (n) (%) (%) (%) (Seconds) Ca 2÷ Rest (nM) (n): Ca 2+ Peak (nM) (AF/F) 
H20 0.60 _+ 0.03 (42) 43 57 0 13.4 _+ 1.8 85 _+ 10 (5) 908 ± 136 (0.71) 
CRT 0.64 .+ 0.03 (53) 55 45 0 23.5 _+ 2.8 d 95 ___ 10 (5) 505 __+ 46 (0.54) 
SERCA2b + H~O 0.88 _.+ 0.05 (34) 0 3 97 2.7 .+ 0.1 103 __. 8 (10) 1473 ± 200 (0.73) 
SERCA2b+CRT 0.87 4- 0.04 (59) 21 32 47 4.6 .+ 0.4 ~ 101 _ 8 (15) 1299 .+ 193(0.68) 
SERCA2b + AC 0.59 _+ 0.04 (22) 46 24 31 4.3 _+ 0.3 f 101 _ 7 (10) 999 .+ 219 (0.58) 
SERCA2b + AP 0.83 __. 0.04 (35) 3 40 57 3.7 .+ 0.2 g 100 _+ 17 (9) 1447 ± 210 (0.79) 
SERCA2b+APC 0.79 _+ 0.05 (27) 0 15 85 2.8 .+ 0.4 96 _+ 12 (7) 1318 _.+ 213 (0.69) 
Mean _+ SEM (n), total number of oocytes in each category. Percent is the percent of (n). 
Represents the largest increase (AF) in Ca 2÷ signal from resting fluorescence (F) throughout he entire recording period. 
b Oocytes with initial large wave (Ca 2+ tide) followed by repetitive waves of Ca 2÷ release. We define repetitive activity as any oscillatory increase 
in Ca 2÷ subsequent to the initial Ca 2÷ tide. 
c Subpopulation of oocytes in which fluorescence was calibrated (see Experimental Procedures). 
CRT is not equivalent to H20 (p < 0.025) (t test). 
e SERCA2b plus CRT is not equivalent to SERCA2b plus H20 (p < 0.025). 
f SERCA2b plus AC is not equivalent to SERCA2b plus H20 (p < 0.1). 
g SERCA2b plus AP is not equivalent to SERCA2b plus H20 (p < 0.025). 
control oocytes (p < 0.005; Table 1), Surprisingly, despite 
the proposed role of CRT in storage of luminal Ca 2÷, over- 
expression of CRT did not increase the amplitude of Ca 2÷ 
waves, suggesting that luminal Ca 2+ storage may not be 
important for the inhibitory action of CRT (see Table 1). 
CRT Inhibits the High Frequency Repetitive Activity 
Elicited By Ca2+-ATPase Overexpression 
To increase the sensitivity of our Ca 2+ assay for CRT func- 
tion, we took advantage of our previous findings showing 
that overexpression of sarcoendoplasmic Ca2+-ATPases 
(SERCA1) increases the frequency of iP3-induced Ca 2÷ 
waves (Camacho and Lechleiter, 1993). When SERCA1 
expression is h igh, no initial tide of Ca 2÷ release is detected 
in response to a bolus injection of IP3, and repetitive activity 
is immediately observed. We expressed SERCA2b mRNA 
in this experiments, since this Ca2÷-ATPase isoform, just 
as CRT, is preferentially expressed in nonmuscle cells 
(Gunteski-Hamblin et al., 1988; Milner et al., 1991). Figure 
1C shows the IP3-induced Ca 2÷ wave activity of an oocyte 
expressing SERCA2b. Oocytes expressing SERCA2b dis- 
play high frequency repetitive activity in response to IP3, 
with no initial Ca 2÷ tide (97%). CRT was also inhibitory in 
this enhanced background of repetitive Ca 2÷ wave activity 
(Figure 1D). Coexpression of CRT with SERCA2b pro- 
duced a larger number of oocytes exhibiting an initial tide 
of Ca 2÷ fol lowed by repetitive activity at significantly lower 
frequency (p < 0.025). Furthermore, 21% of the oocytes 
now showed only an initial tide of Ca 2÷ release with no 
repetitive activity (Table 1). Inhibition of repetitive Ca 2÷ 
waves by CRT was observed in the absence of any change 
in Ca 2÷ wave amplitude, even though the wave amplitude 
in SERCA2b-express ing oocytes was significantly in- 
creased over that in control oocytes (p < 0.01, Table 1). 
Since CRT overexpression did not affect the peak ampli- 
tude of the Ca 2+ response, we suggest that CRT itself may 
behave as a regulator of Ca 2+ release. 
The High Affinity-Low Capacity Ca2+-Binding 
Domain of CRT Inhibits Repetitive Ca 2* Waves 
To determine which domain of CRT is responsible for the 
inhibition of repetitive Ca 2÷ wave activity, we expressed 
SERCA2b with deletion mutants of CRT in which either 
the low aff inity-high capacity domain (AC mutant), the 
high aff inity- low capacity domain (AP mutant), or both 
Ca2+-binding domains (APC mutant) were removed. Since 
wild-type CRT contains the ER-targeting KDEL motif at 
the COOH-terminus (Munro and Pelham, 1987; Pelham, 
1988), all mutants were engineered with this motif to en- 
sure proper targeting. In vitro translations were carried 
out in rabbit reticulocyte lysate to demonstrate that the 
mRNAs encoding mutated proteins yielded appropriately 
sized product (Figure 2A). Western blot analysis demon- 
strated comparable levels of SERCA2b expression in oo- 
cytes when coexpressed with wild-type CRT or with the 
deletion mutants (Figure 2B), Western blot analysis also 
demonstrated expression of CRT, AC, and AP in the same 
oocyte extracts that were probed with anti-SERCA anti- 
body (Figure 2C). Dual labeling confocal immunofluores- 
cence confirmed that CRT, AC, AP, and •PC mutants 
were correctly expressed in the ER and colocalized with 
SERCA2b (Figure 3). 
Our data show that CRT overexpression does not in- 
crease the amplitude of IP3-induced Ca 2÷ waves (Table 1). 
Expression of the AP mutant should directly test whether 
the inhibitory action of CRT is due to an increase in the 
available pool of releasable luminal Ca 2÷, since deletion 
of the P domain should not significantly affect the Ca 2+- 
binding capacity of CRT. On the other hand, if CRT di- 
rectly (or indirectly, via accessory proteins) regulates 
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Figure 3. Confocal Immunocytochemistry of SERCA2b, CRT, and 
CRT Mutants 
(A) Demonstration of colocalization of SERCA2b- and CRT-expressing 
oocyte probed for SERCA2b (C-4 antibody, upper left) and for CRT 
(CRT antibody, upper right). Lower panels show background (no C-4 
antibody) and cross-reactivity staining of CRT secondary antibody with 
C-4 antibody. 
(B) CRT mutant immunofluorescence, as labeled. The colocalization 
pattern of SERCA2b with each mutant was similar to that of CRT in 
(A) (data not shown). Lower right panel shows immunoreactivity of 
endogenous CRT. Dark circles are yolk platelets. Scale bar, -7  I~m. 
Ca2÷-ATPases or IP3Rs, the AC mutant may mimic the 
effects of CRT on repetitive Ca 2+ wave activity, by analogy 
with the role of high affinity Ca2+-binding sites in other 
Ca2+-binding proteins (Nash et al., 1994). Indeed, we found 
that expression of the AP mutant with SERCA2b (Figure 
4A) did not inhibit Ca 2+ repetitive activity. Only 1 of 35 
SERCA2b-AP-expressing oocytes tested failed to exhibit 
repetitive Ca 2÷ waves (Table 1). The AP mutant also had 
no effect on wave amplitude, although we did observe an 
increase in the interwave period. By contrast, when the 
AC mutant was coexpressed with SERCA2b, IP3-induced 
Figure 4. The P Domain of CRT (High Affinity-Low Capacity) Medi- 
ates the Inhibition of Repetitive Ca 2÷ Wave Activity 
(A-C) Comparison of the IP3 (-300 nM)-induced Ca 2+ response in 
SERCA2b coexpressed with the AP mutant (A), with the •C mutant 
(B), and with the APC mutant (C). Individual images were taken at 
indicated times. The bottom trace in each panel represents the change 
in fluorescence (AF/F) for a 5 x 5 pixel area shown as a function of 
time (the 5 x 5 pixel area is shown as in Figure 1). 
(D) Schematic diagram of expression constructs for wild-type CRT and 
deletion mutants (N, P, and C are CRT domains as described in the 
text; KDEL is the COOH-terminus ER retention signal n wild-type CRT 
and CRT deletion mutants). Circles depict Ca2÷-binding sites. Amino 
acids (in single letter code) indicate boundaries between domains for 
each mutant. 
repetitive Ca 2÷ wave activity was markedly reduced (Figure 
4B). Nearly half of the SERCA2b-AC-expressing oocytes 
screened failed to show repetitive activity (Table 1). To 
rule out the possible involvement of the CRT region that 
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contains no Ca2÷-binding domains (N domain; Figure 4D), 
we also coexpressed SERCA2b with the APC mutant. No 
effect on I P3-induced Ca 2÷ wave activity was observed (Fig- 
ure 4C; Table 1). These data demonstrate that the P do- 
main is not only sufficient but also necessary for CRT inhi- 
bition of IP3-induced repetitive Ca 2+ waves. 
Discussion 
Our studies demonstrate that CRT regulates intracellular 
Ca 2+ signaling via the P domain. Interestingly, this domain 
of CRT is highly homologous to calnexin, a chaperone 
protein of the ER (Bergeron et al., 1994). Recent reports 
indicate that CRT may also act as a molecular chaperone 
(Nauseef et al., 1995; Nigam et al., 1994). We suggest 
that interactions of the P domain with either the Ca 2÷- 
ATPase or the IP3R, directly or via an intermediary protein, 
could account for the inhibition of repetitive Ca 2+ waves 
by CRT. In the first case, inhibition of Ca2+-ATPases would 
inhibit cytosolic Ca 2+ clearing, preventing repetitive Ca 2+ 
wave activity subsequent to the initial Ca 2÷ tide. We have 
previously demonstrated that the refilling of Ca 2+ stores by 
overexpression of Ca2+-ATPases shortens the refractory 
period of Ca 2÷ release subsequent to excitation (Camacho 
and Lechleiter, 1993). Alternatively, CRT could stabilize 
the open conformation of the IP3R, prolonging Ca 2+ re- 
lease. The latter mechanism has been proposed for the 
regulation of the ryanodine receptor by the molecular 
chaperone FKBP12 (Brillantes et al., 1994). FKBP12 has 
also been shown to be associated with the IP3R and to 
increase the Ca 2+ flux through this ion channel (Cameron 
et al., 1995). Further, CRT copurifes with IP3R in rat liver 
(Enyedi et al., 1993) and has a similar distribution to that 
of IP3R in Xenopus oocytes (Parys et al., 1994), placing 
the two proteins in proximity for a putative functional inter- 
action. The Ca 2÷ binding to the high affinity P domain may 
have a regulatory function. It is unlikely that the high affinity 
Ca2÷-binding site is occupied when Ca 2+ stores are de- 
pleted. We propose that the physiological function of CRT 
is to prolong an IP3-induced rise in cytosolic Ca 2+, but only 
when Ca 2÷ stores are full and the high affinity Ca2÷-binding 
domain is saturated. When Ca 2+ stores are depleted and 
the high affinity domain is unoccupied, CRT regulation 
may be removed, and the flux of Ca 2÷ could then shift in 
favor of store refilling. The luminal regulation of IP3- 
mediated Ca 2+ release by CRT could operate indepen- 
dently of the cytosolic regulation of the IP3R by Ca 2÷. Alter- 
natively, CRT could shift the Ca 2÷ dependency of the 
IP3-bound receptor, such that higher concentrations of 
Ca 2+ are needed to close the ion channel. Thus, the excit- 
atory mechanism of CICR would still generate a propagat- 
ing wave of Ca 2÷ release. However,  individual waves would 
be terminated more slowly (if at all) by CRT, since inhibition 
of channel gating is less sensitive to high levels of cytosolic 
Ca 2+. Regardless of the precise regulatory mechanism of 
CRT, our data now require that the function of CRT in 
intracellular Ca 2+ signaling be viewed beyond its ability 
simply to sequester Ca 2+. 
Experimental Procedures 
Construction of Expression Vectors 
cDNAs encoding CRT and SERCA2b were subcloned between the 5' 
and 3' untranslated regions (5'UTR and 3'UTR) of Xenopus I~-globin 
expression vector (Melton et al., 1984) (expression vector pGEM- 
HE-Not, gift of E. Liman). We used the polymerase chain reaction 
(PCR) to amplify the full-length cDNA encoding rabbit CRT from plas- 
mid pcDX-CRT (gift of M. Michalak). The forward primer in the PCR 
reaction had sequence 5'-ATCGGAATTCGCCATGCTCCCTGTG- 
CCG-3' and incorporated an EcoRI site at the 5' end ,of CRT. The 
reverse primer sequence had sequence 5'-ATCGAAGCTTCTCTA- 
CAGCTCGTCCTTGGCC-3', incorporating a Hindlll site at the 3' end 
of CRT (all primers synthesized by Operon Technologies). The CRT 
PCR product was gel-isolated, digested with EcoRI and Hindlll, and 
subcloned into expression vector pGEM-HE-Not. To express the SER- 
CA2b Ca2÷-ATPase, we used PCR to amplify the full open reading 
frame from the cDNA RB 2-5, encoding SERCA2b (gift of G. Shull), 
The forward primer in the PCR reaction had sequence 5'-ATGCG- 
GATCCGCCATG GAGAACGCTCACACAAAGACCG-3', incorporating 
a BamHI site at the NH2-terminus of the SERCA2b-encoding cDNA. 
The reverse oligo, with sequence 5'-ATGCAAGCTTGCGCTGTCAGT- 
CAAGACC-3', incorporated a Hindlll site at the 3' end of the SERCA2b 
cDNA. Following PCR amplification, the PCR product was gel-isolated 
and digested with BamHI and Hindlll. The PCR fragment was sub- 
cloned into the vector pGEM-HE-Not, described above, digested with 
BamHI and Hindlll. The resulting plasmid pSERCA2b-HE-Not contains 
the cDNA encoding SERCA2b between the 5'UTR and the 3'UTR of 
Xenopus ~-globin. 
Expression vector for the AP mutant was made by digesting plasmid 
pCRT-HE-Notl (described above) with Bcll and BamHl. Following re- 
moval of the 399 bp fragment (BclI-BamHI), the vector retaining the 
N domain and the C domain was religated to obtain plasmid pCRT- 
AP-HE-Not. The vector to express the AC mutant was engineered by 
PCR using pcDX-CRT as a template and the 5' forward primer de- 
scribed in Figure 1 in conjunction with the reverse primer (5'-GTCG- 
ATCTGCCCGGGCTTCCACTCACC-39, which creates a silent Smal 
site overlapping the amino acid sequence GEWKPRQ. A PCR- 
amplified product of 840 nt (EcoRI-Smal) was digested with Nael and 
Smal, and the 486 nt fragment NaeI-Smal was subcloned into the 
plasmid pCRT-HE-Not, which was digested with Nael (to remove the 
NaeI-Nael fragment) and dephosphorylated with calf intestinal phos- 
phatase (Boeringer Mannheim). Restriction digest analysis was used 
to select the recombinant with the correct orientation. This was con- 
firmed by sequencing the template. The resulting plasmid, pCRT- 
AC-HE-Not, retains domains N and P and terminates with the KDEL 
motif of the wild-type CRT. We constructed plasmid pCRT-APC- 
HE-Not to express a CRT mutant lacking the P and C domains. Plasmid 
pCRT-HE-Not, described above, was digested with Nael to remove a 
NaeI-Nael - 899 bp fragment encoding domains P and C. The vector 
was religated, retaining only the N domain end the KDEL motif at the 
COOH-terminus of wild-type CRT. The boundaries between N, P, and 
C domains of CRT deletion mutants were sequenced with following 
primers. Primer 5'-GCTACGTGAAGCTGTTT-3'was used to sequence 
the boundary between the N and the P domain (in the AC mutant), the 
boundary between the N and the C domain (in the AP mutant), and 
the terminal KDEL following the N domain (in the APC mutant). Primer 
5'-TCGGGGCGAGTACTCATG-3', complementary to the C domain, 
was used to sequence the boundary between the N and the C domains 
(in the Ap mutant). Finally, primer 5'-GCTTAGAGACTCCATTC-3', 
complementary to the 3'UTR of Xenopus 13-globin (in the expression 
vector), was used to sequence the COOH-terminus of all mutants. 
In Vitro Transcriptions 
Plasmids encoding CRT (pCRT-HE-Not), •C (pCRT-AC-HE-Not), Ap 
(pCRT-AP-HE-Not), APC (pCRT-APC-HE-Not), and SERCA2b Ca 2+- 
ATPase (pS2A-HE-Not) were linearized before transcription (Nhel and 
Notl, respectively). Capped synthetic mRNA transcripts were carried 
out with the T7 MegaScript kit (Ambion) according to the instructions 
of the manufacturer. Synthetic mRNAs were resuspended at a concen- 
tration of 1.5-2.0 ~g/p.l. Aliquots of 3 t~l each were stored at -70°C 
until injected into Xenopus oocytes (50 nl bolus). 
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Western Blot Analysis 
Oocyte extracts used in Western blots were prepared from pools of 
five to ten oocytes as previously described (Camacho and Lechleiter, 
1993), except that a freon extraction was carried out to remove yolk 
proteins (Evans and Kay, 1991). The final pellet of each extract was 
resuspended in 6-9 ~1 of 1% SDS per oocyte equivalent, stored frozen 
in aliquots of one oocyte equivalent each. 
In Vitro Translations/Biotinylations 
In vitro translations/biotinylations we re carried out in rabbit reticulocyte 
lysate (Boehringer Mannheim) according to instructions from the man- 
ufacturer. Synthetic mRNAe (3-6 p.g each) encoding CRT, AC and 
AP, and APC were used as input in a 50 p.I volume reaction. 
Confocal Ca 2. Imaging 
Ca 2+ was imaged as previously described (Camacho and Lechleiter, 
1993). In brief, oocytes were injected with a solution of calcium green 
I (50 nl, 250 I~M) 30-60 min prior to each experiment ( -  12.5 p_M final 
concentration, assuming a 1:20 dilution). Images (170 x 170 pixels 
or 256 x 256 pixels) were acquired with a Bio-Rad M RC 600UV confo- 
cal laser scanning microscope at zoom 1.5 attached to a Nikon Diaphot 
with a 10x (0.5 NA) UVfluor Nikon objective lense at 1 s intervals; 
we used Time Course/Ratiometric Software (TCSM; Bio-Rad). The 
confocal aperture was set at the largest opening, producing a 745 x 
745 x 32 pm optical slice. Images were analyzed with ANALYZE 
(Mayo Foundation) on a Sun Sparc2 workstation. Images were not 
filtered for analysis or display. Ca ~÷ increases are reported as AF/F, 
which represents (Fpeak - Fr~t)/Fre,,. On a subpopulation of oocytee, an 
in vivo calibration was carried out at the end of an experiment by 
injecting a 50 nl bolus of 200 mM CaCI2 and 20 p.M thapsigargin to 
obtain a F,~. Fr,~, was estimated as 0.26 x Fma×, on the basis of in 
vitro measurements of fluoresence intensity with (40 I~M) or without 
(1 mM EGTA) Ca 2.. A Kd of 150 nM was used for calcium green I. 
Ca 2+ wave activity was induced by injecting a bolus of 50 nl of IP3 
(Calbiochem) at 6 p.M (-300 nM final concentration, assuming 1:20 
dilution). All recordings were made in the absence of extracellular Ca 2+ 
(96 mM NaCI, 2 mM KCI, 2 mM MgCI2, 5 mM HEPES [pH 7.5] [GIBCO], 
1 mM EGTA [Sigma]). 
Immunofluorescence 
Individual oocytes were saved for immunofluorescence to detect ex- 
pression and targeting of CRT and deletion mutants. Oocytes were 
fixed in 4% paraformaldehyde, 3% sucrose solution for 2 hr at 4°C. 
To remove fixative and initiate rehydration, oocytes were washed twice 
in 20% sucrose, 0.1 M phosphate buffer followed by incubation with 
shaking for 2 hr at 4°C. Oocytes were embedded in acrylamide ac- 
cording to the protocols of Hausen and Dreyer (1991), frozen in a dry 
ice-EtOH bath, and sectioned in 20 I~m slices at -20°C. Slices were 
mounted on glass slides, and nonspecific binding was blocked with 
2% blocking reagent (Boeringher) and 10% horse serum in 1 x TBS 
solution. Oocytes were incubated for 1-2 hr with a rabbit anti-human 
CRT primary antibody (1:30 dilution, Ab PA3-900; Affinity BioRea- 
gents). After primary antibody had been washed three times in 1 x 
TBST, oocyte slices were incubated with LRSC-anti-rabbit secondary 
antibody (1:30 dilution; Jackson Laboratories). Secondary antibody 
was washed again as described above, and the slides were mounted 
in media containing buffered (pH 8.5) polyvinyl alcohol (Mowiol, Calbio- 
chem) prepared according to the protocols of Osborne and Weber 
(1982). Anti-fading agent (n-propyl gallate, or NPG; Sigma) was added 
to the mounting medium at a concentration of 20 g/I (Longing et al., 
1993). For double-labeling immunofluorescence, five groups of oo- 
cytes were injected with mRNA to coexpress SERCA2b, with CRT, 
AC, AP, APC, or H~O for control, and were prepared for immunofluo- 
rescence as described above. Labeling of CRT and CRT deletion mu- 
tants is described above. To label SERCA2b, we used a rabbit primary 
antibody, C-4 (gift of D. MacLenan; this antibody recognizes all rat 
SERCA pumps). Because both primary antibodies in the dual labeling 
experiment are from the same host species (rabbit), we used a conju- 
gated Fab fragment for labeling and blocking the first antigen (Jackson 
Laboratories, example A). To label the SERCA2 antigen, the oocyte 
slices were incubated with C-4 antibody for 60 min at 1:500 dilution in 
1% blocking reagent and 10% don key serum (Jackson Laboratories). 
Following four washes of 3 min each in TBST, incubation with fluores- 
cein ieothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobu- 
lin G (H plus L) (Jackson Laboratories) was performed for 60 rain at 
1:17 dilution. After four washes of 3 rain each in 1 x TBST, a second 
blocking step was added (1% blocking reagent, 10% donkey serum) 
for 30 min. To label the second antigen, the slices were incubated 
with rabbit anti-hCRT primary antibody lAb PA3-900) at 1:100 dilution 
in 1% blocking reagent, 10o/0 donkey serum in 1 x TBS. Following a 
cycle of four washes as above, incubation with the lysamine-rhoda- 
mine (LRSC) donkey anti-rabbit secondary antibody was performed 
for 60 min at a 1:50 dilution. Following a final wash cycle, the slices 
were mounted as described above. The following controls (not all 
shown) were performed in the dual labeling experiment. Control 1, no 
primary CRT antibody, with LRSC secondary antibody; control 2, no 
C-4 or PA3-900 primary antibody; control 3, C-4 primary antibody plus 
Fab FITC; control 4, PA3-900 primary antibody plus LRSC-conjugated 
secondary; and finally, control 5 only with LRSC-conjugated secondary 
antibody, without either of the two primary antibodies. Stained sections 
were imaged with a Bio-Rad MRC 600UV confocal microscope 
adapted to a Nikon Diaphot 200 and a Nikon fluor1.3 oil 100 x objective 
using a fluoroscein and rhodamine filter set (T1/T2A filter cubes from 
Bio-Rad) combined with an argon/krypton laser. 
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